ernie44
8 years ago
also TGX-V widely held it appears by the trading areas
RUBYS
Date Ex Sym Open High Low Close Chg Total Vol #Tr Bid Ask V-TSX-V A-Alpha X-Chi-X H-CX2 P-Pure O-Omega E-TMX Select M-TriAct L-LiquidNet I-Instinet Y-Lynx U-Aequitas
2016-09-09 V TGX 0.005 0.01 0.005 0.005 2,821,425 75 0.005 0.01 1,839,675 100,000 20,000 130,000 404,750 96,000 231,000
can u count 7 markets
surf1944
11 years ago
8:50AM Theragenics extends exclusivity period under letter agreement with Juniper Investment; Juniper affirms $2.25-$2.30 per share proposal (TGX) 2.03 : Co announced that, based on ongoing discussions, the co and Juniper Investment have agreed to extend the exclusivity period under the letter agreement dated May 12, 2013 in connection with Juniper's proposal to acquire all of the co's outstanding common stock. The exclusivity period will now expire at 5:00 p.m. ET on June 18, 2013 unless, prior to such time, Juniper has provided to the co drafts of equity and debt financing commitments in an amount sufficient to fund the proposed transaction, in which case the exclusivity period will be automatically extended until 5:00 p.m. ET on June 25, 2013.
Juniper has expressly reaffirmed its proposal to acquire all of the co's outstanding common stock for $2.25 to $2.30 per share in cash. In connection with the extension of exclusivity, Juniper's proposal anticipates that any definitive merger agreement between the co and Juniper would contain an appropriate "go shop" provision allowing the co, for a period of 35 days (increased from the 30-day period in Juniper's prior proposal) from the date of execution of a definitive merger agreement, to solicit interest from third parties in connection with an alternative business combination.
surf1944
12 years ago
7:15AM Theragenics signs brachytherapy loading services agreement with Oncura, a unit of GE Healthcarecs (TGX) 1.56 : Co announced it has signed a value-added loading services agreement with Oncura, a unit of GE Healthcare, to provide worldwide brachytherapy loading services to Oncura. Under the three-year agreement, Theragenics will load and package Oncura manufactured brachytherapy seeds in prescription loaded needles, custom strands and other configurations. Oncura's iodine-125 brachytherapy seeds are utilized primarily in the treatment of early stage prostate cancer. This agreement provides for loading services for most Oncura sales of prescription and custom loaded brachytherapy seeds worldwide, which currently includes North America, Europe, Australia and portions of Asia.
surf1944
12 years ago
8:12AM Theragenics announces preliminary results of Dutch Auction tender offer; total of 7,119,345 shares were tendered properly and not withdrawn (TGX) 2.08 : In accordance with the terms and conditions of the offer, and based on the preliminary count by the depositary, Theragenics expects to accept for payment an aggregate of 4.76 mln shares of its common stock at a purchase price of $2.10 per share, for a total cost of ~$10.0 mln , excluding fees and expenses related to the tender offer.
surf1944
12 years ago
7:11AM Theragenics receives FDA clearance to market Galt VTI valved tearaway introducer (TGX) 1.72 : Co has received FDA 510(k) clearance to market its Galt VTI valved tearaway introducer. Introducers are utilized for vascular access, with the Galt VTI expected to be utilized primarily for placing catheters. The Galt VTI is expected to be launched in the second half of 2012, with revenue in the range of $300,000 expected in this calendar year based on indications of interest from our customer base. Within twelve months of launch, co expects the Galt VTI to generate annualized revenue of $1 million to $2 million, with gross profit margins higher than currently being realized in the Company's Surgical Products segment.
surf1944
12 years ago
2:06AM Theragenics acquires Core Oncology's prostate brachytherapy customer base; Expected to be accretive to earnings and to generate positive operating cash flow in 2012 (TGX) 1.62 : Co announces that it has purchased Core Oncology's prostate brachytherapy customer base. The asset acquisition was effective on February 17, 2012. The total purchase price is structured as an "earn-out" equal to one times the actual revenue generated from the acquired customers over the twelve month period beginning September 2012 and ending August 2013 in excess of a $2.5 million threshold amount. Theragenics paid $3.8 million in cash at closing as prepayment of a portion of the earn-out, and will make quarterly earn-out payments thereafter. The Company expects to fund the quarterly earn-out payments from operating cash flow and existing cash balances. Additionaly color includes: $5-6 mln of incremental revenue expected in brachytherapy segment for remaining portion of calendar 2012; Expected to be accretive to earnings and to generate positive operating cash flow in 2012; Total earn-out based purchase price is expected to be ~$7.5-10.5 mln, which is based on anticipated revenue in the earn-out period of $10-13 mln from the acquired customers, adjusted for a $2.5 mln threshold amount. Core's prostate brachytherapy sales were ~$13 mln for their fiscal year ended June 30, 2011 and $4 mln for the six months ended December 31, 2011.
Penny Roger$
13 years ago
Theragenics Corporation is a medical device company serving the surgical products and cancer treatment markets. The Company operates in two segments: the surgical products segment and the brachytherapy seed segment. Its surgical products business manufactures, markets and sells disposable devices primarily utilized in certain surgical procedures. Its brachytherapy seed business manufactures, markets and sells radioactive seeds primarily utilized in the treatment of early stage prostate cancer. The Company designs, manufactures, assembles, packages and distributes its surgical products in three primary production facilities, each of which manufactures different products. The product lines in its surgical products business include Sutures, Needles and Brachytherapy Accessories, Guidewires, Micro-Introducer Kits, Tearaway Introducer Sets and Kits, Elite HV Introducer Kits and ReDial 4cm High Flow Introducer Sheath.
http://www.google.com/finance?q=TGX